Stock comparison
Boston Scientific
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BSX
Boston Scientific
Market cap
$85.88B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BSX | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 63C | 75B | IDXX |
| Benjamin Graham | 69B | 80A | IDXX |
| Philip Fisher |
Side-by-side metrics
| Metric | BSX | IDXX |
|---|---|---|
| Market cap | $85.88B | $44.12B |
| P/E (TTM) | 22.0x | 39.0x |
| EV/EBIT | 22.1x | 31.6x |
| ROIC (TTM) | 9.9% | 40.66% |
| Gross margin | 70.41% | 62.05% |
| Net margin | 17.24% | 24.63% |
| Revenue CAGR 5y | 13.99% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BSX leads on
- EPS CAGR 5y29.71%vs 10.79%+64%
- Market cap$85.88Bvs $44.12B+49%
- Revenue CAGR 5y13.99%vs 7.56%+46%
- P/E (TTM)22.0xvs 39.0x
More like IDXX
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.